Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs Vale SA (VALE) Price & Performance

Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs Vale SA — how do they compare? Intuitive Surgical, Inc. trades at $400 (market cap $138.97B), while Vale SA trades at $14.37 (market cap $62.26B). The key difference: Intuitive Surgical, Inc. is far larger — about 2.2× Vale SA's market cap, and Vale SA pays a 8.12% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

ISRGVALE
Market Cap
$138.97B$62.26B
Sector
HealthBasic Materials
52-Week High
$592.85$17.82
52-Week Low
$332.02$9.71
Enterprise Value
$133.76B$78.50B
Dividend Yield
8.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $378.81, up 1.36% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals despite premium valuations (P/E 43.44, P/S 12.35), supported by robust revenue growth reaching $10.06B in 2025 and expanding profit margins of 28.45%. Recent news highlights da Vinci 5 adoption driving procedure growth beyond urology.

Outlook remains positive with 68% analyst buy ratings and $519.05 price target suggesting 37% upside. Key risks include competitive pressure from Medtronic/J&J robots and potential U.S. procedure softness. The combination of durable demand and innovation pipeline supports long-term growth potential for MedTech investors.

Vale SA

VALE trades at $14.71, showing minimal daily movement with a slight decline of 0.07%. The stock faces technical bearish signals from moving averages while fundamentals reveal mixed performance with declining net income margins from 42.85% in 2022 to 5.11% in 2026, despite recent revenue stabilization. Recent earnings misses in Q4 2025 and Q1-Q2 2026 highlight operational challenges, though the company maintains strong cash flow generation of $8.8 billion from operations in 2025.

VALE presents a cautious investment case with analyst consensus leaning neutral (51.35% hold) despite a $16.79 price target suggesting 14% upside. Key opportunities include copper segment growth and disciplined capital returns, while risks involve rising operational costs, earnings volatility, and governance concerns highlighted by recent board disputes. The stock's valuation at 29.42 P/E appears stretched given profitability declines.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG

About Vale SA

Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.

Read more on VALE